Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1 Propyl 2',6' Pipecoloxylidide
2. 1-propyl-2',6'-pipecoloxylidide
3. Al 381
4. Al-381
5. Al381
6. Lea 103
7. Lea-103
8. Lea103
9. Naropeine
10. Naropin
11. Ropivacaine Hydrochloride
12. Ropivacaine Monohydrochloride
13. Ropivacaine Monohydrochloride, (s)-isomer
1. 84057-95-4
2. (s)-ropivacaine
3. Naropin
4. Ropivacaine [inn]
5. Ropivacaine Hydrochloride
6. Ropivacaina
7. Ropivacainum
8. Ropivacaina [spanish]
9. (s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
10. Ropivacainum [inn-latin]
11. Ropivacaina [inn-spanish]
12. (2s)-n-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
13. Ropivicaine
14. 7io5lya57n
15. (-)-1-propyl-2',6'-pipecoloxylidide
16. Lea 103
17. Chebi:8890
18. Tlc590
19. (2s)-n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide
20. (2s)-n-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide
21. Tlc-590
22. Ropivacaine (inn)
23. L-n-n-propylpipecolic Acid-2,6-xylidide
24. Lea-103
25. 2-piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2s)-
26. S-ropivacaine
27. (s)-(-)-1-propyl-2',6'-pipecoloxylidide
28. 1-propyl-2',6'-pipecoloxylidide
29. Noropine
30. Narop
31. Lea-103 Hcl
32. Naropin (tn)
33. Ncgc00164597-01
34. Ropivacaine [inn:ban]
35. 98717-15-8
36. Unii-7io5lya57n
37. Ropivacaine Base
38. Mfcd00864425
39. Al-381
40. Ropivacaine [mi]
41. Ropivacaine [vandf]
42. Schembl33292
43. Ropivacaine [usp-rs]
44. Ropivacaine [who-dd]
45. Bidd:gt0203
46. Narop; Noropine; Lea-103
47. Gtpl7602
48. (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilid
49. Chembl1077896
50. Dtxsid4040187
51. Zinc897002
52. Hy-b0563
53. Bbl102321
54. S5504
55. Stl556120
56. Akos017343283
57. Ccg-267197
58. Db00296
59. As-35173
60. Cs-0009514
61. R0251
62. C07532
63. D08490
64. Ab00698466-07
65. Ab00698466_10
66. 057r954
67. A840710
68. Q279504
69. (s)-(-)-1-propyl-2',6'-pipecoloxylidine
70. Q-201677
71. (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide
72. (s)-n-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide
73. (s)-(-)-1-propylpiperidine-2-carboxylic Acid (2,6-dimethylphenyl)amide
| Molecular Weight | 274.4 g/mol |
|---|---|
| Molecular Formula | C17H26N2O |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 274.204513457 g/mol |
| Monoisotopic Mass | 274.204513457 g/mol |
| Topological Polar Surface Area | 32.3 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 308 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Naropin |
| PubMed Health | Ropivacaine (Injection) |
| Drug Classes | Anesthetic, Local |
| Drug Label | Naropin Injection contains ropivacaine HCl which is a member of the amino amide class of local anesthetics. Naropin Injection is a sterile, isotonic solution that contains the enantiomerically pure drug substance, sodium chloride for isotonicity an... |
| Active Ingredient | Ropivacaine hydrochloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2mg/ml; 10mg/ml; 5mg/ml; 7.5mg/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa |
| 2 of 2 | |
|---|---|
| Drug Name | Naropin |
| PubMed Health | Ropivacaine (Injection) |
| Drug Classes | Anesthetic, Local |
| Drug Label | Naropin Injection contains ropivacaine HCl which is a member of the amino amide class of local anesthetics. Naropin Injection is a sterile, isotonic solution that contains the enantiomerically pure drug substance, sodium chloride for isotonicity an... |
| Active Ingredient | Ropivacaine hydrochloride |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 2mg/ml; 10mg/ml; 5mg/ml; 7.5mg/ml |
| Market Status | Prescription |
| Company | Fresenius Kabi Usa |
Used in obstetric anesthesia and regional anesthesia for surgery.
FDA Label
Ropivacaine, a local anesthetic agent, is indicated for the production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures.
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
N01BB09
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N01 - Anesthetics
N01B - Anesthetics, local
N01BB - Amides
N01BB09 - Ropivacaine
Absorption
Bioavailability is 87%98% following epidural administration.
Route of Elimination
Ropivacaine is extensively metabolized in the liver, predominantly by aromatic hydroxylation mediated by cytochrome P4501A to 3-hydroxy ropivacaine. After a single IV dose approximately 37% of the total dose is excreted in the urine as both free and conjugated 3-hydroxy ropivacaine. In total, 86% of the ropivacaine dose is excreted in the urine after intravenous administration of which only 1% relates to unchanged drug.
Clearance
387+/- 107 mL/min
unbound plasma clearance=7.2 +/- 1.6 L/min
Hepatic
Ropivacaine has known human metabolites that include 3-hydroxy-ropivacaine and PPX.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Approximately 4.2 hours.
Local anesthetics such as Ropivacaine block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Specifically, they block the sodium-channel and decrease chances of depolarization and consequent action potentials. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 48954-722
Start Marketing Date : 2009-11-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53335-0003
Start Marketing Date : 2021-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76339-126
Start Marketing Date : 2019-12-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (19.999kg/19.999kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61876-0071
Start Marketing Date : 2010-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1159
Start Marketing Date : 2011-09-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66583-0610
Start Marketing Date : 1998-05-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49386-022
Start Marketing Date : 2019-08-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49386-025
Start Marketing Date : 2019-08-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17381-506
Start Marketing Date : 2010-05-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72375-0004
Start Marketing Date : 2020-12-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : Yes
TE Code : AP
Brand Name : NAROPIN
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 100MG/20ML (5MG/ML)
Approval Date : 1998-05-01
Application Number : 20533
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : Yes
TE Code : AP
Brand Name : NAROPIN
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 150MG/20ML (7.5MG/ML)
Approval Date : 1996-09-24
Application Number : 20533
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 200MG/100ML (2MG/ML)
Approval Date : 2022-08-18
Application Number : 210102
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 400MG/200ML (2MG/ML)
Approval Date : 2022-08-18
Application Number : 210102
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 40MG/20ML (2MG/ML)
Approval Date : 2020-07-20
Application Number : 214074
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD :
TE Code :
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 5MG/ML(0.5%)
Approval Date :
Application Number : 78601
RX/OTC/DISCN :
RLD :
TE Code :
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 150MG/30ML (5MG/ML)
Approval Date : 2014-07-17
Application Number : 78601
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 200MG/100ML (2MG/ML)
Approval Date : 2023-10-26
Application Number : 206091
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 400MG/200ML (2MG/ML)
Approval Date : 2023-10-26
Application Number : 206091
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AP
Brand Name : ROPIVACAINE HYDROCHLORIDE
Dosage Form : SOLUTION;INJECTION
Dosage Strength : 150MG/30ML (5MG/ML)
Approval Date : 2016-04-11
Application Number : 203955
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
Regulatory Info :
Registration Country : France
Brand Name :
Dosage Form : Solution for Infusion
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
Packaging :
Regulatory Info :
Dosage : Solution for Infusion
Dosage Strength : 2MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : France
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Solution for Infusion ...
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Packaging :
Regulatory Info : EU Approved
Dosage : Solution for Infusion ...
Dosage Strength : 2MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Solution for injection...
Dosage Strength : 2MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Packaging :
Regulatory Info : EU Approved
Dosage : Solution for injection...
Dosage Strength : 2MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Solution for injection...
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Packaging :
Regulatory Info : EU Approved
Dosage : Solution for injection...
Dosage Strength : 5MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Solution for injection...
Dosage Strength : 7.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Packaging :
Regulatory Info : EU Approved
Dosage : Solution for injection...
Dosage Strength : 7.5MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Solution for injection...
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Packaging :
Regulatory Info : EU Approved
Dosage : Solution for injection...
Dosage Strength : 10MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Greece
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 2MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : Brazil
Brand Name : ROPI
Dosage Form : INJECTION
Dosage Strength : 2MG/ML
Packaging : 5 AMPS X 20 ML (Sterile Pack)
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Brazil
Packaging : 5 AMPS X 20 ML (Sterile Pack)
Regulatory Info : Generic
Dosage : INJECTION
Dosage Strength : 2MG/ML
Brand Name : ROPI
Approval Date :
Application Number :
Registration Country : Brazil
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 5MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 5MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : India
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INJECTION - 100MG/10ML (10M...DOSAGE - SOLUTION;INJECTION - 100MG/10ML (10MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 100MG/20ML (5MG...DOSAGE - SOLUTION;INJECTION - 100MG/20ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 150MG/30ML (5MG...DOSAGE - SOLUTION;INJECTION - 150MG/30ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 150MG/20ML (7.5...DOSAGE - SOLUTION;INJECTION - 150MG/20ML (7.5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 1GM/200ML (5MG/...DOSAGE - SOLUTION;INJECTION - 1GM/200ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 200MG/20ML (10M...DOSAGE - SOLUTION;INJECTION - 200MG/20ML (10MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 200MG/100ML (2M...DOSAGE - SOLUTION;INJECTION - 200MG/100ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 20MG/10ML (2MG/...DOSAGE - SOLUTION;INJECTION - 20MG/10ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 400MG/200ML (2M...DOSAGE - SOLUTION;INJECTION - 400MG/200ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 40MG/20ML (2MG/...DOSAGE - SOLUTION;INJECTION - 40MG/20ML (2MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 500MG/100ML (5M...DOSAGE - SOLUTION;INJECTION - 500MG/100ML (5MG/ML)
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 50MG/10ML (5MG/...DOSAGE - SOLUTION;INJECTION - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20533
DOSAGE - SOLUTION;INJECTION - 75MG/10ML (7.5M...DOSAGE - SOLUTION;INJECTION - 75MG/10ML (7.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20533
Related Excipient Companies
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
US Patents
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Health Canada Patents
Patent Expiration Date : 2014-05-26
Date Granted : 2005-07-05
Brand Name : NAROPIN
Patent Number : 2165446
Filing Date : 1994-05-26
Strength per Unit : 2 mg/ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Infiltration/nerve block/epidural for injection
Patent Expiration Date : 2014-05-26
Date Granted : 2005-07-05
Patent Expiration Date : 2014-05-26
Date Granted : 2005-07-05
Brand Name : NAROPIN
Patent Number : 2165446
Filing Date : 1994-05-26
Strength per Unit : 5 mg/ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Infiltration/nerve block/epidural for injection
Patent Expiration Date : 2014-05-26
Date Granted : 2005-07-05
Patent Expiration Date : 2012-11-14
Date Granted : 1995-11-14
Brand Name : NAROPIN
Patent Number : 1337549
Filing Date : 1989-06-08
Strength per Unit : 5 mg/ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Infiltration/nerve block/epidural for injection
Patent Expiration Date : 2012-11-14
Date Granted : 1995-11-14
Patent Expiration Date : 2012-11-14
Date Granted : 1995-11-14
Brand Name : NAROPIN
Patent Number : 1337549
Filing Date : 1989-06-08
Strength per Unit : 2 mg/ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Infiltration/nerve block/epidural for injection
Patent Expiration Date : 2012-11-14
Date Granted : 1995-11-14
Patent Expiration Date : 2014-05-26
Date Granted : 2005-07-05
Brand Name : NAROPIN
Patent Number : 2165446
Filing Date : 1994-05-26
Strength per Unit : 10 mg/ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Infiltration/nerve block/epidural for injection
Patent Expiration Date : 2014-05-26
Date Granted : 2005-07-05
Patent Expiration Date : 2012-11-14
Date Granted : 1995-11-14
Brand Name : NAROPIN
Patent Number : 1337549
Filing Date : 1989-06-08
Strength per Unit : 10 mg/ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Infiltration/nerve block/epidural for injection
Patent Expiration Date : 2012-11-14
Date Granted : 1995-11-14
Patent Expiration Date : 2004-02-10
Date Granted :
Brand Name :
Patent Number : 1217773
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-02-10
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2004-02-10
Date Granted :
Brand Name :
Patent Number : 1217773
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-02-10
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2004-02-10
Date Granted :
Brand Name :
Patent Number : 1217773
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-02-10
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2004-02-10
Date Granted :
Brand Name :
Patent Number : 1217773
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2004-02-10
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
EDQM
CAS Number : N/A
Quantity Per Vial : 5 mg
Sale Unit : 1
Order Code : Y0000743
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C
Ropivacaine hydrochloride monohydrate
CAS Number : 132112-35-7
Quantity Per Vial : 10 mg
Sale Unit : 1
Order Code : Y0000742
Batch No : 1
Price (€) : 79
Storage : +5°C ± 3°C
CAS Number : 73360-54-0
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : B1160000
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]USP
CAS Number : 84057-95-4
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1605497
Current Lot : F0J017
Previous Lot :
NDC Code :
Ropivacaine Hydrochloride (200 mg)
CAS Number : 132112-35-7
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1605500
Current Lot : R047V0
Previous Lot : F0E334 (31-AUG-2017)
NDC Code :
Ropivacaine Related Compound A (25 mg) (2,6-d...
CAS Number : 21436-98-6
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1605512
Current Lot : R023M0
Previous Lot : F0E315 (31-MAR-2016)
NDC Code :
Others
CAS Number : 27262-48-2
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.09
CAS Number : 27262-40-4
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.02
CAS Number : 24358-84-7
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.03
CAS Number : 112773-90-7
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.07
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.08
Ropivacaine Hydrochloride Monohydrate
CAS Number : 84057-95-4
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.00
CAS Number : 27262-48-2
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.01
CAS Number : 98626-59-6
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.04
CAS Number : 265120-58-9
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.05
CAS Number : 1945965-95-6
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : R0035.06
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
